Osaic Holdings
CALT

Osaic Holdings’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Osaic Holdings’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-255
Closed -$9.94K – 7596
2024
Q2 		$9.94K Sell
255
-849
-77% -$23.3K ﹤0.01% 5794
2024
Q1 		$23.2K Sell
1,104
-68
-6% -$1.51K ﹤0.01% 5263
2023
Q4 		$30.2K Buy
1,172
+5
+0.4% +$94 ﹤0.01% 5240
2023
Q3 		$21.3K Hold
1,167
– – ﹤0.01% 5518
2023
Q2 		$18.5K Buy
1,167
+1,003
+612% +$21.2K ﹤0.01% 5620
2023
Q1 		$3.93K Hold
164
– – ﹤0.01% 6452
2022
Q4 		$3K Hold
164
– – ﹤0.01% 6557
2022
Q3 		$3K Hold
164
– – ﹤0.01% 6694
2022
Q2 		$3K Buy
164
+1
+0.6% +$17 ﹤0.01% 6788
2022
Q1 		$3K Hold
163
– – ﹤0.01% 6797
2021
Q4 		$4K Hold
163
– – ﹤0.01% 6806
2021
Q3 		$3K Buy
163
+51
+46% +$1.4K ﹤0.01% 6788
2021
Q2 		$3K Buy
+112
New +$3.21K ﹤0.01% 6641

Other funds holding CALT

CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return

Osaic Holdings's CALT Position: Q3 2024 in Review

Osaic Holdings sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q3 2024, closing a stake of 255 shares — an estimated $9.94K sold.

Osaic Holdings first reported a position in CALT in Q2 2021 and held it in 13 quarters. The position peaked at $30.2K in Q4 2023. 5 funds tracked by Wall St. Rank hold CALT as of Q3 2024.

  • Osaic Holdings reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Osaic Holdings sold 255 Calliditas Therapeutics AB American Depositary Shares shares in Q3 2024, an estimated $9.94K.
  • Osaic Holdings first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q2 2021 and held it in 13 quarters.
  • Osaic Holdings's Calliditas Therapeutics AB American Depositary Shares position peaked at $30.2K in Q4 2023.
  • 5 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q3 2024.

Based on Osaic Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.